Alyeska Investment Group’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-147,458
| Closed | -$96K | – | 600 |
|
|
2017
Q3 | $96K | Buy |
+147,458
| New | +$96K | ﹤0.01% | 449 |
|
|
2017
Q1 | – | Sell |
-147,458
| Closed | -$102K | – | 625 |
|
|
2016
Q4 | $102K | Hold |
147,458
| – | – | ﹤0.01% | 459 |
|
|
2016
Q3 | $209K | Hold |
147,458
| – | – | ﹤0.01% | 442 |
|
|
2016
Q2 | $240K | Hold |
147,458
| – | – | ﹤0.01% | 416 |
|
|
2016
Q1 | $314K | Sell |
147,458
-43,043
| -23% | -$119K | ﹤0.01% | 371 |
|
|
2015
Q4 | $739K | Sell |
190,501
-31,393
| -14% | -$119K | 0.01% | 350 |
|
|
2015
Q3 | $763K | Buy |
221,894
+13,935
| +7% | +$59.2K | 0.01% | 406 |
|
|
2015
Q2 | $1.03M | Buy |
207,959
+52,558
| +34% | +$232K | 0.01% | 407 |
|
|
2015
Q1 | $763K | Sell |
155,401
-34,897
| -18% | -$161K | 0.01% | 449 |
|
|
2014
Q4 | $790K | Sell |
190,298
-7,048
| -4% | -$32K | 0.01% | 413 |
|
|
2014
Q3 | $1.14M | Sell |
197,346
-9,337
| -5% | -$56.2K | 0.02% | 318 |
|
|
2014
Q2 | $1.43M | Buy |
+206,683
| New | +$1.59M | 0.03% | 337 |
|
Alyeska Investment Group's PARN Position: Q4 2017 in Review
Alyeska Investment Group sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q4 2017, closing a stake of 147,458 shares — an estimated $96K sold.
Alyeska Investment Group first reported a position in PARN in Q2 2014 and held it in 12 quarters. The position peaked at $1.43M in Q2 2014. 1 fund tracked by Wall St. Rank holds PARN as of Q4 2017.
- Alyeska Investment Group reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q4 2017 after selling out during the quarter.
- Alyeska Investment Group sold 147,458 Parnell Pharmaceuticals Holdings Ltd shares in Q4 2017, an estimated $96K.
- Alyeska Investment Group first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q2 2014 and held it in 12 quarters.
- Alyeska Investment Group's Parnell Pharmaceuticals Holdings Ltd position peaked at $1.43M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q4 2017.
Based on Alyeska Investment Group's 13F filing for Q4 2017, filed 14 Feb 2018.